Logo image of 703.DE

ALFEN N.V. (703.DE) Stock Fundamental Analysis

FRA:703 - Deutsche Boerse Ag - NL0012817175 - Common Stock - Currency: EUR

16.735  +1.79 (+11.98%)

Fundamental Rating

3

703 gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 54 industry peers in the Electrical Equipment industry. 703 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 703 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year 703 has reported negative net income.
703 had a positive operating cash flow in the past year.
703 had positive earnings in 4 of the past 5 years.
Each year in the past 5 years 703 had a positive operating cash flow.
703.DE Yearly Net Income VS EBIT VS OCF VS FCF703.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

703 has a Return On Assets of -7.45%. This is in the lower half of the industry: 703 underperforms 68.52% of its industry peers.
703 has a Return On Equity of -17.74%. This is in the lower half of the industry: 703 underperforms 68.52% of its industry peers.
Industry RankSector Rank
ROA -7.45%
ROE -17.74%
ROIC N/A
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
703.DE Yearly ROA, ROE, ROIC703.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

703 has a Gross Margin (31.09%) which is in line with its industry peers.
703's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for 703 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
703.DE Yearly Profit, Operating, Gross Margins703.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

703 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 703 remains at a similar level compared to 1 year ago.
Compared to 5 years ago, 703 has more shares outstanding
The debt/assets ratio for 703 has been reduced compared to a year ago.
703.DE Yearly Shares Outstanding703.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
703.DE Yearly Total Debt VS Total Assets703.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 2.83 indicates that 703 is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.83, 703 is doing good in the industry, outperforming 77.78% of the companies in the same industry.
The Debt to FCF ratio of 703 is 1.59, which is an excellent value as it means it would take 703, only 1.59 years of fcf income to pay off all of its debts.
703 has a Debt to FCF ratio of 1.59. This is amongst the best in the industry. 703 outperforms 88.89% of its industry peers.
703 has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
703's Debt to Equity ratio of 0.28 is fine compared to the rest of the industry. 703 outperforms 74.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.59
Altman-Z 2.83
ROIC/WACCN/A
WACC7.28%
703.DE Yearly LT Debt VS Equity VS FCF703.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

703 has a Current Ratio of 1.68. This is a normal value and indicates that 703 is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 703 (1.68) is comparable to the rest of the industry.
703 has a Quick Ratio of 1.68. This is a bad value and indicates that 703 is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of 703 (1.00) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1
703.DE Yearly Current Assets VS Current Liabilites703.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

The earnings per share for 703 have decreased strongly by -191.15% in the last year.
703 shows a decrease in Revenue. In the last year, the revenue decreased by -3.34%.
The Revenue has been growing by 27.79% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-191.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.64%
Revenue 1Y (TTM)-3.34%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%67.79%

3.2 Future

Based on estimates for the next years, 703 will show a very strong growth in Earnings Per Share. The EPS will grow by 55.47% on average per year.
Based on estimates for the next years, 703 will show a small growth in Revenue. The Revenue will grow by 4.40% on average per year.
EPS Next Y527.24%
EPS Next 2Y184.12%
EPS Next 3Y101.07%
EPS Next 5Y55.47%
Revenue Next Year1.97%
Revenue Next 2Y5.44%
Revenue Next 3Y6.31%
Revenue Next 5Y4.4%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
703.DE Yearly Revenue VS Estimates703.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
703.DE Yearly EPS VS Estimates703.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

703 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 24.54, which indicates a rather expensive current valuation of 703.
703's Price/Forward Earnings is on the same level as the industry average.
703's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.86.
Industry RankSector Rank
PE N/A
Fwd PE 24.54
703.DE Price Earnings VS Forward Price Earnings703.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, 703 is valued a bit cheaper than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.65
EV/EBITDA N/A
703.DE Per share data703.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

703's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 703's earnings are expected to grow with 101.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y184.12%
EPS Next 3Y101.07%

0

5. Dividend

5.1 Amount

703 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALFEN N.V.

FRA:703 (5/2/2025, 7:00:00 PM)

16.735

+1.79 (+11.98%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)05-12 2025-05-12
Inst Owners48.06%
Inst Owner ChangeN/A
Ins Owners0.55%
Ins Owner ChangeN/A
Market Cap363.99M
Analysts76
Price Target16.51 (-1.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.89%
PT rev (3m)0.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)8.12%
EPS NY rev (3m)4.01%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.88%
Revenue NY rev (3m)-3.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 24.54
P/S 0.75
P/FCF 11.65
P/OCF 6.52
P/B 2.39
P/tB 2.9
EV/EBITDA N/A
EPS(TTM)-1.24
EYN/A
EPS(NY)0.68
Fwd EY4.08%
FCF(TTM)1.44
FCFY8.59%
OCF(TTM)2.57
OCFY15.34%
SpS22.42
BVpS7
TBVpS5.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.45%
ROE -17.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.09%
FCFM 6.41%
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
F-Score5
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.59
Debt/EBITDA N/A
Cap/Depr 93.52%
Cap/Sales 5.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1
Altman-Z 2.83
F-Score5
WACC7.28%
ROIC/WACCN/A
Cap/Depr(3y)181.87%
Cap/Depr(5y)166.2%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-191.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.64%
EPS Next Y527.24%
EPS Next 2Y184.12%
EPS Next 3Y101.07%
EPS Next 5Y55.47%
Revenue 1Y (TTM)-3.34%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%67.79%
Revenue Next Year1.97%
Revenue Next 2Y5.44%
Revenue Next 3Y6.31%
Revenue Next 5Y4.4%
EBIT growth 1Y-172.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1104.06%
EBIT Next 3Y152.15%
EBIT Next 5Y74.68%
FCF growth 1Y207.54%
FCF growth 3YN/A
FCF growth 5Y33.38%
OCF growth 1Y890.24%
OCF growth 3Y74.32%
OCF growth 5Y31.69%